Document Detail

Analysis of troponin I levels after spontaneous implantable cardioverter defibrillator shocks.
MedLine Citation:
PMID:  11900289     Owner:  NLM     Status:  MEDLINE    
INTRODUCTION: Serum cardiac troponin I (cTnI) is a sensitive and specific marker for myocardial injury. Myocardial ischemia and/or injury can be a trigger for ventricular arrhythmias. The aim of this study was to assess the frequency and significance of elevated serum cTnI levels after spontaneous implantable cardioverter defibrillator (ICD) shocks. METHODS AND RESULTS: Serial cTnI measurements and ECGs were performed in 35 patients with transvenous ICDs who were admitted after spontaneous ICD shocks. Elevated cTnI levels were found in 18 patients (51%). Acute coronary syndrome was diagnosed in 5 (22%) of 23 patients with known coronary artery disease. After excluding the patients with acute coronary syndrome, elevated cTnI levels were present in 13 (43%) of 30 patients: 18% of patients with < or =3 shocks and 58% of patients with >3 shocks. Patients with elevated cTnI levels received a higher number of shocks (16+/-18 vs 5+/-7; P < 0.05) and had higher total delivered energies (475+/-538 J vs 128+/-184 J; P < 0.05) compared with patients with normal cTnI. Patients with acute coronary syndrome had higher peak cTnI levels (18+/-16 ng/mL) compared with patients with elevated cTnI without acute coronary syndrome (3.8+/-4.3 ng/mL; P < 0.01). CONCLUSION: Serum cTnI rises occur in the majority of patients after multiple (>3) spontaneous ICD discharges but are due to acute coronary syndrome only 14% of the time (22% of the time in patients with known coronary artery disease).
Can Hasdemir; Nayyar Shah; Arun P Rao; Helbert Acosta; Kagari Matsudaira; Barbara R Neas; Dwight W Reynolds; Sunny Po; Ralph Lazzara; Karen J Beckman
Related Documents :
16479099 - Antiplatelet therapy after percutaneous coronary intervention.
1625339 - Anger and impatience/irritability in patients of low socioeconomic status with acute co...
1590229 - Simultaneous transesophageal two-dimensional echocardiography and atrial pacing for det...
7029229 - Nifedipine in medically refractory angina pectoris.
15979079 - The monocytic lineage specific soluble cd163 is a plasma marker of coronary atheroscler...
19450889 - Plaque components at coronary sites with focal spasm in patients with variant angina: v...
9590419 - Prevalence of barrett's esophagus in hispanics is similar to caucasians.
19549429 - Perception of acute airway function changes by patients with mild asthma.
7976229 - Motor impairment in wilson's disease. 3: the clinical impact of pyramidal tract involve...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of cardiovascular electrophysiology     Volume:  13     ISSN:  1045-3873     ISO Abbreviation:  J. Cardiovasc. Electrophysiol.     Publication Date:  2002 Feb 
Date Detail:
Created Date:  2002-03-19     Completed Date:  2002-10-02     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  9010756     Medline TA:  J Cardiovasc Electrophysiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  144-50     Citation Subset:  IM    
Cardiac Arrhythmia Research Institute and Cardiovascular Section, The University of Oklahoma Health Sciences Center, Oklahoma City 73104, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Atrial Fibrillation / blood*,  therapy
Creatine Kinase / blood
Creatine Kinase, MB Form
Defibrillators, Implantable / adverse effects*
Isoenzymes / blood
Middle Aged
Multivariate Analysis
Myocardium / metabolism*
Retrospective Studies
Troponin I / blood*
Reg. No./Substance:
0/Isoenzymes; 0/Troponin I; EC Kinase; EC Kinase, MB Form

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Sustained monomorphic ventricular tachycardia ablation from the aortic sinus of valsalva.
Next Document:  Effects of verapamil and ibutilide on atrial fibrillation and postfibrillation atrial refractoriness...